You are here: Industry Insights > SINOVAC BIOTECH

News List

Sinovac Biotech signs up to supply COVAX with CoronaVac cphi-online
July 15, 2021
China-based company could supply up to 380 million doses from July 2021 through to June 2022
Sinovac’s CoronaVac triggers quick immune response in Covid-19 trial pharmaceutical-technology
November 19, 2020
Sinovac Biotech has reported the preliminary results from Phase I/II trial that showed its experimental Covid-19 vaccine, CoronaVac, triggered a quick immune response in healthy adults.
CoronaVac from Sinovac triggers quick immune response expresspharma
November 19, 2020
The Sinovac findings came from results in Phase I and Phase II clinical trials in China involving over 700 participants.
Sinovac begins Covid-19 vaccine candidate trials in Turkey pharmaceutical-business-review
September 27, 2020
Chinese biopharmaceutical company Sinovac Biotech has begun phase III clinical trials for its inactivated Covid-19 vaccine candidate in Turkey.
China’s Sinovac starts late stage trials for its COVID-19 vaccine expresspharma
July 09, 2020
China’s Sinovac Biotech is starting Phase III trials of its potential coronavirus vaccine in Brazil, it said on Monday, becoming one of three companies to move into the late stages in the race to develop an inoculation against the disease.
‘At war time speed’, China leads COVID-19 vaccine race expresspharma
July 08, 2020
Sinovac Biotech’s experimental vaccine set to become the country’s second and the world’s third to enter final stage testing later this month.
China’s Sinovac Biotech gets funding for Covid-19 vaccine development pharmaceutical-technology
May 26, 2020
Chinese biopharmaceutical products company Sinovac Biotech has received $15m in funding to advance the development of its Covid-19 vaccine candidate, CoronaVac.
Sinovac Biotech to move ahead with COVID-19 vaccine trial in China pharmaceutical-business-review
April 17, 2020
Sinovac Biotech has secured approval in China to move ahead with a human clinical trial on an inactivated vaccine candidate against the SARS-CoV-2 virus (novel coronavirus or COVID-19).
China approves two experimental coronavirus vaccines to enter clinical trials expresspharma
April 16, 2020
The vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech , and by the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group.
Sinovac Amends Shareholder Rights Plan prnasia
March 07, 2018
Sinovac Biotech Ltd. today announced that its board of directors has amended its shareholder rights plan. The amendment extends the expiration date of the plan from March 27, 2018 to March 27, 2019.

Previous page 1 2 Next page